ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

RESEARCH STUDY TO IDENTIFY THE MEASURES OF MYOCARDIUM IN DIABETIC AND NON-DIABETIC PATIENTS CURED WITH PROTEOLYTIC ENZYME HAVING (MG) MOIETYGLORIFICATION

Dr. Quratulain Majeed Kayani, Dr. Rameesha Rashid, Dr. Nabeel Riaz

Objective: Research study was held to relate the effectiveness of proteolytic enzyme in (CD) cardiovascular disease with diabetic and non-diabetic patients with sore throat section exaltation. Study Design: A random medical experiment. Place and Duration of Study: This research study was held for the duration of one year from November 2017 to November, 2018 at Holy Family Hospital, Rawalpindi. Method: The myocardium patients with sore throat section exaltation were engaged from the department of cardiology of Holy Family Hospital, Lahore. Results: The primary features of selected patients with diabetic and non-diabetic MI {myocardial infraction}, the average age of the patients in both selected sets were same and 48.53±3.34 in diabetics and 47.45±3.26 in the set. The male patients of diabetic were 76.6% and of non-diabetics were 83.4%. An association of streptococcal action was documented in the non-diabetic and diabetic patients in ST section elevation, the patients with diabetic were only 32% and the patients with non-diabetic were 86%. Conclusion: Our research study was concluded that clot-dissolving medication in more effective in diabetic patients than in patients with {STEMI} sore throat elevation myocardial infarction diabetes; though, it is necessary that extra care should be paid to the patients of diabetic before clot-dissolving medication is managed. Key words: Efficacy, clot dissolving medication, sore throat elevation myocardial infarction, Diabetic, Nondiabetic, streptokinase.

FULL TEXT